Influence of the microbiome, diet and genetics on inter-individual variation in the human plasma metabolome.

Chen L, Zhernakova DV, Kurilshikov A, Andreu-Sánchez S, Wang D, Augustijn HE, Vich Vila A, Lifelines Cohort Study, Weersma RK, Medema MH, Netea MG, Kuipers F, Wijmenga C, Zhernakova A, Fu J. · 2022

Read Influence of the microbiome, diet and genetics on inter-individual variation in the human plasma metabolome. by Chen L, Zhernakova DV, Kurilshikov A, Andreu-Sánchez S, Wang D, Augustijn HE, Vich Vila A, Lifelines Cohort Study, Weersma RK, Medema MH, Netea MG, Kuipers F, Wijmenga C, Zhernakova A, Fu J. (2022) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc9671809.txt.

Introduction

Chen and co-authors weigh how microbiome, diet, and genetics shape the human plasma metabolome. Blood holds thousands of small molecules from body work. Their levels vary a lot from person to person. The sources of that spread were only partly charted.

The team measured 1,183 plasma metabolites in 1,368 people. All came from two deeply profiled Dutch cohorts. Diet led the account, with 610 metabolites tied most to it. The gut microbiome led for 85 metabolites in the count. Genetics led for just 38 metabolites in the same tally. A score built from metabolites tracked real diet quality well. Causal probes linked gut species to single molecules. One tied Eubacterium rectale to lower hydrogen sulfite levels. A repeat visit set of 311 people, four years apart, tested stability.

Catalog record

CREATORChen L, Zhernakova DV, Kurilshikov A, Andreu-Sánchez S, Wang D, Augustijn HE, Vich Vila A, Lifelines Cohort Study, Weersma RK, Medema MH, Netea MG, Kuipers F, Wijmenga C, Zhernakova A, Fu J.
YEAR2022
COLLECTIONPAPERS
FORMATTXT
FILE SIZE92 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC9671809

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Influence of the microbiome, diet and genetics on inter-individual variation in the human plasma metabolome By Lianmin Chen, Daria V Zhernakova, Alexander Kurilshikov, Sergio Andreu-Sánchez, Daoming Wang, Hannah E Augustijn, Arnau Vich Vila, Rinse K Weersma, Marnix H Medema, Mihai G Netea, Folkert Kuipers, Cisca Wijmenga Published in: Nature Medicine DOI: 10.1038/s41591-022-02014-8 ABSTRACT Abstract The levels of the thousands of metabolites in the human plasma metabolome are strongly influenced by an individual’s genetics and the composition of their diet and gut microbiome. Here, by assessing 1,183 plasma metabolites in 1,368 extensively phenotyped individuals from the Lifelines DEEP and Genome of the Netherlands cohorts, we quantified the proportion of inter-individual variation in the plasma metabolome explained by different factors, characterizing 610, 85 and 38 metabolites as dominantly associated with diet, the gut microbiome and genetics, respectively. Moreover, a diet quality score derived from metabolite levels was significantly associated with diet quality, as assessed by a detailed food frequency questionnaire. Through Mendelian randomization and mediation analyses, we revealed putative causal relationships between diet, the gut microbiome and metabolites. For example, Mendelian randomization analyses support a potential causal effect of Eubacterium rectale in decreasing plasma levels of hydrogen sulfite—a toxin that affects cardiovascular function. Lastly, based on analysis of the plasma metabolome of 311 individuals at two time points separated by 4 years, we observed a positive correlation between the stability of metabolite levels and the amount of variance in the levels of that metabolite that could be explained in our analysis. Altogether, characterization of factors that explain inter-individual variation in the plasma metabolome can help design approaches for modulating diet or the gut microbiome to shape a healthy metabolome. Subject terms: Genetics, Microbial communities, Metagenomics, Epidemiology MAIN The plasma metabolome represents a functional readout of metabolic activities within different organs and tissues of the body. Levels of specific plasma metabolites may therefore reflect the presence of specific diseases or an individual’s susceptibility to developing complex metabolic diseases such as cardiovascular and kidney disorders, diabetes, cancers and Crohn’s disease1. Elucidating the genetic, dietary and microbial factors that shape human metabolism is crucial for understanding the origin and determinants of plasma metabolites, and hence for the eventual design of intervention strategies aimed at a healthy metabolome. Inter-individual variations in the human plasma metabolome have already been linked to genetics, diet and the gut microbiome in several cohort-based studies1–4. For instance, a reference map of potential determinants of the human serum metabolome was established in 491 individuals from an Israeli cohort, and the authors reported 335 metabolites that were significantly explained by diet and 182 that were explained by the gut microbiome3. More recently, the Personalized Responses to Dietary Composition Trial assessed the impact of diet and the microbiome on host metabolism in 1,098 individuals from the United Kingdom and United States and observed that the microbial species associated with healthy dietary habits overlapped with those associated with favorable cardiometabolic and postprandial markers4. As diet, genetics and the gut microbiome are highly heterogeneous between different countries, we aimed to: (1) systematically identify dietary, genetic and microbial factors that are associated with plasma metabolites; (2) identify which of the three factors (diet, genetics or the microbiome) explains the most inter-individual variability in metabolites compared with the other two (the dominant factor); and (3) assess their causal relationships using in silico approaches. To do so, we quantified the plasma levels of 1,183 metabolites in 1,368 individuals from the population-based Lifelines DEEP (LLD)5 and Genome of the Netherlands (GoNL)6 cohorts, including LLD1 (n = 1,054), LLD2 (n = 237) and GoNL (n = 77). In addition, 311 LLD1 individuals were followed up after 4 years7. For each participant, we had information on the gut microbiome, genetic background and dietary habits. In addition, we assessed whether diet-associated metabolites can be used to predict an individual’s dietary quality score reflecting diet‒disease relationships8 and examined whether genetics-associated metabolites can pinpoint dysregulated molecular pathways in complex diseases. Importantly, as potential causal relationships among metabolites, diet and the microbiome remain largely unexplored, metabolites associated with multiple factors offered us an opportunity to infer their underlying causality using Mendelian randomization (MR) and mediation analyses9. RESULTS Untargeted plasma metabolites in Dutch cohorts In this study, we examined plasma metabolomes in 1,679 fasting plasma samples from 1,368 individuals from two LLD5 sub-cohorts (LLD1 and LLD2) and the GoNL6 cohort (Extended Data Fig. 1 and Supplementary Table 1). The LLD1 cohort was the discovery cohort, with information about genetics, diet and the gut microbiome available for 1,054 participants. Moreover, 311 LLD1 subjects were followed up 4 years later (LLD1 follow-up). We also included two independent replication cohorts: 237 LLD2 participants for whom we had genetic and dietary data and 77 GoNL participants for whom only genetic data were available (Extended Data Fig. 1 and Supplementary Table 1). Untargeted metabolomics profiling was done using flow-injection time-of-flight mass spectrometry (FI-MS)10,11, which yielded plasma levels of 1,183 metabolites (Supplementary Table 2). These metabolites covered a wide range of lipids, organic acids, phenylpropanoids, benzenoids and other metabolites (Extended Data Fig. 2a). As we observed weak (absolute rSpearman < 0.2) correlations among the 1,183 metabolites (Extended Data Fig. 2b), data reduction was not required and, consequently, all metabolites were subjected to subsequent analyses. We validated the identification and quantification of some metabolites (for example, bile acids, creatinine, lactate, phenylalanine and isoleucine) by comparing their abundance levels from FI-MS with those previously determined by liquid chromatography with tandem mass spectrometry (LC-MS/MS)12 or NMR13 (rSpearman > 0.62; Extended Data Fig. 2c,d). [Figure: Overview of study cohorts and analysis workflow.a. Summary of cohorts and datasets involved in the analyses. b. Detailed analysis workflow of the present study.] [Figure: Summary of plasma metabolites.a. Number of metabolites per metabolic categories based on annotation in the HMDB database. The x-axis indicates number of metabolites per category. The number of metabolites is also shown. The y-axis indicates metabolic categories. b. Inter-correlation between metabolites in the LLD baseline samples. Rows and columns represent metabolites. Color scheme represents the Spearman correlation coefficient. c. Comparison of metabolite concentrations between un-targeted FI-MS and LC-MS/MS platforms. The x-axis indicates metabolic abundance determined by LC-MS/MS. The y-axis indicates metabolic abundance determined by FI-MS. Each gray dot represents one sample. The red dashed line is the best fit line of linear regression with 95% confidence interval (CI). Spearman correlation coefficient between two measurements and the corresponding P value (two-sided) are shown. d. Comparison of metabolite concentrations between un-targeted FI-MS and NMR platforms. The x-axis indicates metabolic abundance determined by NMR and the y-axis indicates metabolic abundance determined by FI-MS. Each gray dot represents one sample. The red dashed line is the best fit line of linear regression with 95% CI. Spearman correlation coefficients between two measurements and the corresponding P value (two-sided) are shown.] Factors explaining inter-individual metabolome variations To compare the relative importance of diet, genetics and the gut microbiome in explaining inter-individual plasma metabolome variability, we calculated the proportion of variance explained by these three factors for the whole plasma metabolome profile and for the individual metabolites separately. We have detailed information on 78 dietary habits (Supplementary Table 3), 5.3 million human genetic variants and the abundances of 156 species and 343 MetaCyc pathways

Read the complete text